Indium (111In) imciromab

From WikiMD's WELLNESSPEDIA


Indium (111In) imciromab
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status withdrawn
CAS Number 126132-83-0
PubChem
DrugBank
ChemSpider none
KEGG


Indium (111In) imciromab (trade name Myoscint) is a mouse monoclonal antibody labelled with the radioisotope Indium-111.[1] It was used for cardiac imaging, but withdrawn in 1993.[2]

See also[edit]

References[edit]

  1. ↑ WHO Drug Information
  2. ↑ DiagnosticImaging.com: Centocor withdraws imaging agent applications


Diagnostic radiopharmaceuticals (V09)
Central nervous system
Skeletal system
Renal
Gastrointestinal/Hepatic
Respiratory system
Isotopes used:
See also: Therapeutic radiopharmaceuticals (V10)


Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems
Bone ("-os-", "-s(o)-")
Human ("-osu-")
Humanized ("-sozu-")
Musculoskeletal ("-mul-")
Human ("-mulu-")


Stub icon

This monoclonal antibody–related article is a stub. You can help WikiMD by expanding the page.

Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Indium_(111In)_imciromab&oldid=6524471"